Ocular Therapeutix Inc. (OCUL)

4.50
0.07 1.40
NASDAQ : Health Technology
Prev Close 4.56
Open 4.47
Day Low/High 4.21 / 4.68
52 Wk Low/High 2.35 / 7.31
Volume 766.34K
Avg Volume 900.60K
Exchange NASDAQ
Shares Outstanding 42.84M
Market Cap 208.19M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

A Summer Friday Has Me Hunting for New Stock Ideas

A Summer Friday Has Me Hunting for New Stock Ideas

The important thing to remember on days like this is to not read too much into the action.

Three to Watch in Biotech

Other than the Dow, most of major market indices are showing small gains heading into the last hour of trading. The biotech sector has not participated in today's rally and is down someĀ 0.75% on the day so far. I am watching a few small biotech and ...

Markets Recovering From Latest Trump Tweetstorm

Markets Recovering From Latest Trump Tweetstorm

Wall Street discounting talk of bombing Syria from president.

Biotechs Take the Lead This Morning

Biotechs Take the Lead This Morning

Whether this market continues to bounce is going to depend a great degree on the FAANG names.

Dip Buyers Are Losing Their Confidence -- And They Have No Interest in Facebook

Dip Buyers Are Losing Their Confidence -- And They Have No Interest in Facebook

The longer the stock market goes without a better bounce, the bigger the risk.

You Trading Small-Cap Stocks? You Should Be

You Trading Small-Cap Stocks? You Should Be

Right now this is a market for stock pickers and not timers.

Mid-Afternoon Update

2:15 pm update Markets are pretty much where they were 90 minutes ago. The S&P has strengthened a bit and overall equities have held up better than I thought given the potential partial government shutdown this weekend. We will see if stocks hold th...

These Stocks Are Changing Directions

These Stocks Are Changing Directions

Bullish and bearish reversals in the market.

3 Small Biotechs on the FDA Summer Calendar

3 Small Biotechs on the FDA Summer Calendar

Dynavax Technologies, Ocular Therapeutix and Neos Therapeutics have big drug approval dates ahead.

Keep Biotech Trigger Fingers Holstered

Keep Biotech Trigger Fingers Holstered

Three names show how fast biotechs can become oversold when the market acts in knee-jerk fashion.

Scanning the Mid-Morning Landscape

The market and 10-year Treasury yield are taking disappointing first-quarter GDP number in stride. The Chicago PMI came in stronger than expected and growth should rebound in the second quarter. Consumer spending was weak in first quarter, especiall...

3 Small Biotechs With Insider Buying

3 Small Biotechs With Insider Buying

Insiders have an edge in this complex sector, so it's worth checking them out.